Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
Titel:
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
Auteur:
Liu, Zhigang Le, Kaixing Zhou, Xin Alexander, James L Lin, Simeng Bewshea, Claire Chanchlani, Neil Nice, Rachel McDonald, Timothy J Lamb, Christopher A Sebastian, Shaji Kok, Klaartje Lees, Charlie W Hart, Ailsa L Pollok, Richard C Boyton, Rosemary J Altmann, Daniel M Pollock, Katrina M Goodhand, James R Kennedy, Nicholas A Ahmad, Tariq Powell, Nick
Verschenen in:
The Lancet gastroenterology & hepatology
Paginering:
Jaargang 8 () nr. 2 pagina's 145-156
Jaar:
2023
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license